Hyperthyroidism. Thyrotoxicosis, unspecified
Conditions
Interventions
Intervention 1: Intervention group: methimazole with a dose of 10 to 20 mg per day plus a capsules containing 350 mg of extract of the plant during 3months. Intervention 2: Control group: methimazole
Sponsors
Sari University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Age between twenty to sixty years Patients with a higher level of FT4 hormones have a parity of 17 pg /L Patients with a FT3 serum level Larger than equal to 5.7 pg/ml Patients with a lower serum TSH level equal to MU / I0.4
Exclusion criteria
Exclusion criteria: Patients with a history of underlying illness, such as diabetes or hypertension or liver failure, such as cirrhosis of the liver and kidney or heart disease, according to patients referenced Use other medications Use cigarettes right now Alcoholism Pregnant patients Lactating patients Patients who have taken an antithyroid drug for the last three months Patient with ALT levels are twice the normal range Patients who are required to receive other medications for the treatment of other illness during the study Patients who experience side effects such as itching or headache or allergies to the drug Requesting a patient or his family to leave the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Level of thyroid hormones. Timepoint: First of the study (before the intervention) and 30, 60 and 90 days after the start of the capsule. Method of measurement: Collection of questionnaires and laboratory tests and periodic clinical examinations. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Farzameh
Sari University of Medical Sciences
Outcome results
None listed